| S&P Global Healthcare Sector Index Fund (IXJ) |
The iShares S&P Global Healthcare Sector Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies that Standard & Poor's deems part of the healthcare sector of the economy and important to global markets, as represented by the S&P Global Healthcare Sector Index. The index is a subset of the Standard & Poor's Global 1200 Index.
Fund Inception Date: 11/13/2001
| NAV as of 7/2/2009 | Price as of 7/2/2009 | ||
|---|---|---|---|
| Net Asset Value | $42.39 | Price | $42.44 |
| Change | $-1.00 | Change | $-0.73 |
| Change | -2.31% | Change | -1.69% |
| Profile as of 7/2/2009 | Fundamentals as of 5/29/2009 | ||
|---|---|---|---|
| Total Net Assets (000) | $442,951 | Price/Earnings | 16.04 |
| Shares Outstanding | 10,450,000 | Price/Book | 3.29 |
| Management Fees | 0.48% | Beta (vs. S&P 500) |
0.68 |
| Acquired Fund Fees & Expenses‡ | 0.00% | ||
| Total Annual Fund Operating Expenses | 0.48% | ||
| Yield as of 5/29/2009 | |||
|---|---|---|---|
| 1.56 | |||
| Trading Information | |||
|---|---|---|---|
| Related Index | SGH | Shares Outstanding | IXJ.SO |
| NAV | IXJ.NV | Total Cash | IXJ.TC |
| Und. Trading Value | IXJ.IV | CUSIP | 464287325 |
| Est. Cash | IXJ.EU | ||
| Options Available | |||
| Top Holdings* (Daily) as of 7/2/2009 | |
|---|---|
| View All Holdings | |
| 8.80% | JOHNSON&JOHN SON |
| 6.07% | NOVARTIS AG-REG |
| 5.57% | PFIZER INC |
| 5.45% | ROCHE HOLDING AG-GENUSSCHEIN |
| 5.15% | GLAXOSMITHKLINE PLC |
| 4.08% | ABBOTT LABORATORIES |
| 3.58% | ASTRAZENECA PLC |
| 3.50% | SANOFI-AVENTIS |
| 3.41% | WYETH |
| 3.25% | MERCK&CO. INC. |
| Top Sectors as of 7/2/2009 | |
|---|---|
| 78.27% | Pharmaceuticals Biotechnology & Life Sci |
| 21.22% | Health Care Equipment & Services |
| 0.10% | S-T Securities |
Carefully consider the Funds' investment objectives, risk factors and charges and expenses before investing. This and other information can be found in the Funds' prospectuses, which may be obtained by calling 1-800-iShares (1-800-474-2737) or click here to view or download a prospectus. Read the prospectus carefully before investing.
Investing involves risk, including possible loss of principal.
‡ “Acquired Fund Fees and Expenses” reflect the Fund's pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. Acquired Fund Fees and Expenses are reflected in the prices of the acquired funds and thus included in the total returns of the Fund.
The iShares Funds ("Funds") are distributed by SEI Investments Distribution Co. (SEI). Barclays Global Fund Advisors (BGFA) serves as the investment advisor to the Funds. BGFA is a subsidiary of Barclays Global Investors, N.A., a majority-owned subsidiary of Barclays Bank PLC, none of which is affiliated with SEI.
In addition to the normal risks associated with investing, international investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from economic or political instability in other nations.
Narrowly focused investments typically exhibit higher volatility.
Health care companies are subject to extensive government regulation and their profitability can be affected by restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure, and malpractice or other litigation.
Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of Characteristics and Risks of Standardized Options. Copies of this document may be obtained from your broker, from any exchange on which options are traded or by contacting The Options Clearing Corporation, One North Wacker Dr., Suite 500 Chicago, IL 60606 (1-800-678-4667). The document contains information on options issued by The Options Clearing Corporation. The document discusses exchange-traded options issued by The Options Clearing Corporation and is intended for educational purposes. No statement in the document should be construed as a recommendation to buy or sell a security or to provide investment advice.
If you need further information, please feel free to call the Options Industry Council Helpline. They will be able to provide you with balanced options education and tools to assist you with your iShares options questions and trading. The Options Industry Council Helpline phone number is 888-Options and their website is www.888Options.com.
S&P and Standard & Poor's are trademarks of The McGraw-Hill Companies, Inc. and have been licensed for use by Barclays Global Investors, N.A. iShares Funds are not sponsored, endorsed, issued, sold or promoted by Standard & Poor's. Nor does this company make any representation regarding the advisability of investing in iShares Funds. Index data source: Standard & Poors.
Shares of iShares Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Certain sectors and markets perform exceptionally well based on current market conditions and iShares funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.
©2009 Barclays Global Investors. All rights reserved. iShares® is a registered trademark of Barclays Global Investors, N.A.. All other trademarks, servicemarks or registered trademarks are the property of their respective owners.
Investing involves risk, including possible loss of principal.
‡ “Acquired Fund Fees and Expenses” reflect the Fund's pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. Acquired Fund Fees and Expenses are reflected in the prices of the acquired funds and thus included in the total returns of the Fund.
The iShares Funds ("Funds") are distributed by SEI Investments Distribution Co. (SEI). Barclays Global Fund Advisors (BGFA) serves as the investment advisor to the Funds. BGFA is a subsidiary of Barclays Global Investors, N.A., a majority-owned subsidiary of Barclays Bank PLC, none of which is affiliated with SEI.
In addition to the normal risks associated with investing, international investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from economic or political instability in other nations.
Narrowly focused investments typically exhibit higher volatility.
Health care companies are subject to extensive government regulation and their profitability can be affected by restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure, and malpractice or other litigation.
Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of Characteristics and Risks of Standardized Options. Copies of this document may be obtained from your broker, from any exchange on which options are traded or by contacting The Options Clearing Corporation, One North Wacker Dr., Suite 500 Chicago, IL 60606 (1-800-678-4667). The document contains information on options issued by The Options Clearing Corporation. The document discusses exchange-traded options issued by The Options Clearing Corporation and is intended for educational purposes. No statement in the document should be construed as a recommendation to buy or sell a security or to provide investment advice.
If you need further information, please feel free to call the Options Industry Council Helpline. They will be able to provide you with balanced options education and tools to assist you with your iShares options questions and trading. The Options Industry Council Helpline phone number is 888-Options and their website is www.888Options.com.
S&P and Standard & Poor's are trademarks of The McGraw-Hill Companies, Inc. and have been licensed for use by Barclays Global Investors, N.A. iShares Funds are not sponsored, endorsed, issued, sold or promoted by Standard & Poor's. Nor does this company make any representation regarding the advisability of investing in iShares Funds. Index data source: Standard & Poors.
Shares of iShares Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Certain sectors and markets perform exceptionally well based on current market conditions and iShares funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.
©2009 Barclays Global Investors. All rights reserved. iShares® is a registered trademark of Barclays Global Investors, N.A.. All other trademarks, servicemarks or registered trademarks are the property of their respective owners.
© Copyright 2009